Proxemis
David Leah is a seasoned business development professional with extensive experience in the pharmaceutical industry. Currently serving as Business Development Director at Citeline since September 2024, David previously held the same title at EMIS from April 2023 to September 2024. David's career includes significant roles at Pfizer, where David was Regional Sales Manager and National Healthcare Development Manager, focusing on market strategy and revenue growth for rare disease medications. Additional experience includes positions at Daiichi Sankyo Co., Ltd. as a Hospital Account Executive, Boehringer Ingelheim as a Hospital Specialist, and GSK as a Therapy Specialist. David holds a BA in Law (Hons), Law and Economics from the University of Nottingham, obtained between 2005 and 2008.
This person is not in any teams
This person is not in any offices
Proxemis
We're reimagining research to support healthier lives with our customisable end to end clinical trial solution. Combining the world-renowned expertise of the University of Oxford’s Department of Primary Care, with the software, clinical reach and data management capabilities of EMIS, Proxemis is uniquely positioned to tackle recruitment challenges and offer a tailored experience for clinical trial delivery, specialising in primary care. Leveraging market leading point of care systems used and trusted in over 10,000 healthcare organisations across the UK, Proxemis integrates research delivery into day-to-day care to address long term conditions and health inequalities. By focusing particularly on clinical trials that are suited to be conducted in community settings, Proxemis aims to make it easier for both patients and clinicians to participate in research, help find better treatments for long-term conditions and deliver research that is truly representative of the UK.